期刊文献+

IL-1β对人体皮肤成纤维细胞增殖的影响 被引量:4

Effects of Interleukin-1β on Proliferation of Fibroblast in Vitro
下载PDF
导出
摘要 目的探讨白介素-1β(interleukin-1β,IL-1β)对人体皮肤成纤维细胞增殖的影响及其可能机制。方法胶原酶消化法提取人皮肤成纤维细胞(human skin fibroblasts,HFB)。分别用0,0.04,0.2,1与5 ng/m L浓度的IL-1β培养HFB 24 h,以0 ng/m L浓度的IL-1β培养HFB 24 h为对照组,采用流式细胞分析法测定各组细胞周期分布情况,MTT法测定各组细胞增殖情况。结果细胞周期分析结果显示,各实验组与对照组相比,S期所占比例增加,且随着培养液中IL-1β浓度增高,S期所占比例上升。MTT法测定结果表明,各实验组OD值均比对照组高,且实验组OD值随着培养液中IL-1β浓度增高而增高。细胞周期和MTT结果均表明,IL-1β浓度为5 ng/m L时,其促进细胞增殖的效果最明显。结论 IL-1β浓度是影响HFB增殖的重要因素,本实验为创伤后表皮细胞和真皮细胞大量分泌IL-1β并促进HFB增殖的现象提供了参考。 Objective To study the effects of interleukin-1β on proliferation of human fibroblasts (HFB) in vitro, and the possible mechanisms. Methods HFB were isolated using collagenase digestion method, and cuhured with IL-1β at concentrations of 0.04, 0. 2, 1 and 5ng/mL for 24 hours. The HFB cultured without IL-1β served as controls. Flow cytometry was used to determine cell cycle, and MTT assay was used to assess the proliferation of HFB. Results In comparison with the controls, IL-1β increased both the S-phase fraction of HFB and OD values, as determined by flow cytometry and MTT assay, respectively. Both the portion of S- phase HFB and OD values were positively correlated the IL-1β concentrations. Both flow cytometry and MTT results demonstrated that IL-1β at the concentration 5 ng/mL was most effective in stimulating HFB prolifera- tion. Conclusion The concentration of IL-1β is a key factor affecting HFB proliferation. The present studies explain why that both epidermal and dermal cells secrete IL-1β and stimulate HFB proliferation following injury.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第6期565-568,共4页 The Chinese Journal of Dermatovenereology
基金 国家自然科学基金(11372208) 山西省自然科学基金(2013011002-4)
关键词 IL-1Β 成纤维细胞 增殖 细胞周期 MTT IL-1β fibroblast proliferation cell cycle MTT
  • 相关文献

参考文献22

  • 1Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and ke- loids: pathomechanisms and current and emerging treatment strategies [J]. Molecular Medicine,2011,17(1 -2) : 113 - 125.
  • 2Profyfis C, Tziotzios C, Do Vale I. Cutaneous scarring : Pathophysiology, molecular mechanisms,and scar reduction therapeutics. Part I. The mo- lecular basis of scar formatiom[ J]. Journal of the American Academy of Dermatology,2012,66( 1 ) :1 - 10.
  • 3张振,章一新.增生性瘢痕治疗的研究进展[J].组织工程与重建外科杂志,2010,6(3):178-180. 被引量:18
  • 4Grishkevich VM. Ankle dorsiflexion posthum scar contractures: Anatomy and reconstructive techniques [ J ]. Burns,2012,38 ( 6 ) : 882 - 888.
  • 5Viera MH ,Amini S, V alins W,et al. Innovative therapies in the treatment ofkeloids and hypertrophic scars [ J ]. J Clin Aesthet Dermatol,2010,3 ( 5 ) : 20 - 26.
  • 6刘阳,许卫玮,安美文,邱海霞,茹孟洁.不同分化的角质形成细胞对成纤维细胞增殖及胶原合成的影响[J].中国皮肤性病学杂志,2013,27(11):1092-1095. 被引量:3
  • 7Vesey DA,Cheung C,Cuttlr L,et al. Interleukin-lbeta stimulates human re- nal flbroblastproliferation and matrix protein production by means of a trans- forming growth factor-dependent mechanism[J]. J Lab Clin Med ,2002,140 (5) : 342 -350.
  • 8Schimidt TA, Mizel SB. Interleuk-1, a potential regulator of fibroblast proliferation[ J]. Immunol, 1982,128 : 2177 - 2182.
  • 9Wang J,Dodd C,Shankowsky HA,et al. Deep dermal fibroblasts contribute to hypearophic Scarring[J]. Lab Invest,2/X ,88(12) : 1278 - 1290.
  • 10Lawrence JW, Mason ST, Schomer K. Epidemiology and impact of scar- fing after bum injury:a systematic review of the literature[ J]. J Burn Care Res,2012,33( 1 ) :136 - 146.

二级参考文献72

  • 1孙少萍,邵柏.PTTG及c-myc与恶性肿瘤[J].齐鲁医学杂志,2004,19(5):459-461. 被引量:3
  • 2连小华,杨恬,蔡绍皙,杨力.诱导表皮角质形成细胞体外分层的途径及机制[J].第三军医大学学报,2005,27(12):1201-1203. 被引量:4
  • 3厉孟,张琳西,夏炜,郭树忠.角质形成细胞源促成纤维细胞增殖的细胞因子研究[J].中国美容医学,2006,15(4):374-376. 被引量:8
  • 4Reiber GE, Lipsky BA, Gibben GW. The burden of diabetic foot ulcers[J]. Am J Surg, 1998, 176, 2 : 5-10.
  • 5New JP, McDowell E, Burns E, et al Problem of amputations in patients with newly diagnosed diabetes[J]. Diabetic Med, 1998, 15: 760- 769.
  • 6Loots MA, Lamme EN, Mekkes JR, et al. Cultured fibroblasts from chrnic diabetic wounds on the lower extremity(non-insulin dependent diabetes mellitus)show disturbed prolfferation[J].Arch Dermatol Res, 1999, 291: 93-99.
  • 7Chen C, Schultz GS, Bloch M, et al. Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds[J].. Wound Repair Regen, 1999, 7: 486-494.
  • 8Siwik DA, Chang DI, Colucci WS, et al. Interleukin -1 beta and tumor necrosis factor -alpha decrease collagen synthesis and increase matrix mctalloprotcinase activity in cardiac fibroblasts in vitrol[J]. Circ Res, 2000, 86: 1259-1265.
  • 9Lobmunn R, Ambrosch A, Schultz G, et al. Expression of matrix- metalloprotienases and their inhibitors in the wounds of diabetic and non-diabetic patients[J]. Diabetologia, 2002, 45: 1011-1016.
  • 10Monica CT,Willem MV,Magda MW,et al.Prevention and curative management of hypertrophic scar formation[J].Burns,2009,35(4):463-475.

共引文献44

同被引文献33

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部